Ticker
NEOCompany Name
NEOGENOMICS INCSector
HealthcareIndustry
Diagnostics & ResearchExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ 14.05M | 2.04% | $ 689.19M |
3/31/2025 | $ 7.61M | 1.13% | $ 672.36M |
12/31/2024 | $ 7.02M | 1.06% | $ 660.57M |
9/30/2024 | $ 15.01M | 2.33% | $ 644.12M |
6/30/2024 | $ 264K | 0.04% | $ 628.25M |
3/31/2024 | $ -15.18M | -2.49% | $ 610.66M |
12/31/2023 | $ -1.95M | -0.33% | $ 591.64M |
9/30/2023 | $ -23.42M | -4.07% | $ 574.8M |
6/30/2023 | $ -34.2M | -6.2% | $ 551.62M |
3/31/2023 | $ -49.65M | -9.37% | $ 529.78M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / Revenues
(=) OCF %
OCF % for NEOGENOMICS INC is calculated as follows: CF - Operations [ $ -1.17M ] / Revenues [ $ 425.32M ]
(=) OCF % [ -0.27% ]
Minimum
Sep 30, 2022
Maximum
Mar 31, 2021
Average
Median
filtered constituents | 3.25K |
---|---|
min | -57.27% |
max | 77.08% |
average | 14.31% |
median | 12.65% |
std | 21.13% |